Page 213 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 213
P0543 COMPARATIVE EVALUATION OF THE ARTUS HBV QS- ePOSTERS
P0544 RGQ ASSAY AND THE ROCHE COBAS AMPLIPREP/COBAS
P0545 TAQMAN V.2 HBV TEST FOR THE QUANTIFICATION OF HBV
P0546 DNA IN PLASMA
Segolene Brichler*, Samira Dziri, Alexandra Duhant, Grace Faleu,
P0547 Emmanuel Gordien, France
P0548
INNATE AND ADAPTIVE IMMUNE RESPONSES CORRELATE
WITH PEGINTERFERON ALFA TREATMENT EFFICACY
IN CHRONIC HEPATITIS B PATIENTS (THE OSST
IMMUNOLOGY STUDY)
Weiming Yan*, Di Wu, Xiaojing Wang, Qintao Lai, Qi Zheng, Jiaji Jiang,
Jinlin Hou, Meifang Han, Qin Ning, China
TARGETING VIRAL DNA WITH CRISPR/CAS9 ROBUSTLY
SUPPRESSES HEPATITIS B VIRUS
Amir Shlomai*, Vyas Ramanan, David B. Cox, Robert E. Schwartz,
Eleftherios Michailidis, Ankit Bhatta, Feng Zhang, Sangeeta N. Bhatia,
Charles M. Rice, Israel
INVIVO IMPACT OF PRECORE MUTATIONS OF
HBV ON VIRAL REPLICATIVE CAPACITY, VIRAL
PROTEIN PROCESSING, AND VIRION ASSEMBLY.
MOLECULAR CORRELATES OF HISTOLOGIC AND
IMMUNOHISTOCHEMICAL ASPECTS IN LIVER TISSUE
FROM PATIENTS WITH CHRONIC HEPATITIS B
Claudia Minosse, Andrea Baiocchini, Sabrina Coen, Paola Zaccaro,
Ubaldo Visco Comandini, Raffaella Lionetti, Marzia Montalbano,
Franca Del Nonno, Marco Vivarelli, Giampiero D’Offizi,
Maria R. Capobianchi, Stefano Menzo*, Italy
PHYLOGEOGRAPHY OF GLOBAL HBV GENOTYPE D
REVEAL THE CENTRAL ROLE OF CENTRAL ASIA IN
DISSEMINATING THE EPIDEMIC
Dimitrios Paraskevis*, Evangelia Kostaki, Gkikas Magiorkinis, Simon Ho,
Angelos Hatzakis, Greece
IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-
CIRRHOTIC CHRONIC HCV PATIENTS COMPARED TO
HEALTHY CONTROLS
Mario G. Pessoa*, Roseane P. Medeiros, Marta Lopes, Daniel Mazo,
Claudia P. Oliveira, Patricia M. Zitelli, João R. Pinho, Flair J. Carrilho,
Brazil
Vienna, Austria • April 22–26, 2015 213
P0544 RGQ ASSAY AND THE ROCHE COBAS AMPLIPREP/COBAS
P0545 TAQMAN V.2 HBV TEST FOR THE QUANTIFICATION OF HBV
P0546 DNA IN PLASMA
Segolene Brichler*, Samira Dziri, Alexandra Duhant, Grace Faleu,
P0547 Emmanuel Gordien, France
P0548
INNATE AND ADAPTIVE IMMUNE RESPONSES CORRELATE
WITH PEGINTERFERON ALFA TREATMENT EFFICACY
IN CHRONIC HEPATITIS B PATIENTS (THE OSST
IMMUNOLOGY STUDY)
Weiming Yan*, Di Wu, Xiaojing Wang, Qintao Lai, Qi Zheng, Jiaji Jiang,
Jinlin Hou, Meifang Han, Qin Ning, China
TARGETING VIRAL DNA WITH CRISPR/CAS9 ROBUSTLY
SUPPRESSES HEPATITIS B VIRUS
Amir Shlomai*, Vyas Ramanan, David B. Cox, Robert E. Schwartz,
Eleftherios Michailidis, Ankit Bhatta, Feng Zhang, Sangeeta N. Bhatia,
Charles M. Rice, Israel
INVIVO IMPACT OF PRECORE MUTATIONS OF
HBV ON VIRAL REPLICATIVE CAPACITY, VIRAL
PROTEIN PROCESSING, AND VIRION ASSEMBLY.
MOLECULAR CORRELATES OF HISTOLOGIC AND
IMMUNOHISTOCHEMICAL ASPECTS IN LIVER TISSUE
FROM PATIENTS WITH CHRONIC HEPATITIS B
Claudia Minosse, Andrea Baiocchini, Sabrina Coen, Paola Zaccaro,
Ubaldo Visco Comandini, Raffaella Lionetti, Marzia Montalbano,
Franca Del Nonno, Marco Vivarelli, Giampiero D’Offizi,
Maria R. Capobianchi, Stefano Menzo*, Italy
PHYLOGEOGRAPHY OF GLOBAL HBV GENOTYPE D
REVEAL THE CENTRAL ROLE OF CENTRAL ASIA IN
DISSEMINATING THE EPIDEMIC
Dimitrios Paraskevis*, Evangelia Kostaki, Gkikas Magiorkinis, Simon Ho,
Angelos Hatzakis, Greece
IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-
CIRRHOTIC CHRONIC HCV PATIENTS COMPARED TO
HEALTHY CONTROLS
Mario G. Pessoa*, Roseane P. Medeiros, Marta Lopes, Daniel Mazo,
Claudia P. Oliveira, Patricia M. Zitelli, João R. Pinho, Flair J. Carrilho,
Brazil
Vienna, Austria • April 22–26, 2015 213
